Brief: Heron Therapeutics Says Selling Stockholders Are Offering 24.7 Million Shares On A Resale Basis
Oct 7 (Reuters) - Heron Therapeutics Inc HRTX.O :
* HERON THERAPEUTICS INC - SELLING STOCKHOLDERS ARE OFFERING
ON A
RESALE BASIS AN AGGREGATE OF 24.7 MILLION SHARES OF COMMON STOCK
OF CO
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop